Toronto Stocks Climb as November CPI Is Steady, G2 Goldfields Rises on New Investment
By Adriano Marchese
Canadian stocks were sharply higher, hoisted by strength across all sectors.
Materials was the main leader in Tuesday's session, followed by consumer discretionary and tech.
On the economic front, Canada's annual inflation rate unexpectedly held steady at 3.1% in November as consumers continue to be squeezed by higher mortgage interest costs, food prices and rent. This was higher than the 2.9% the market was expecting, according to economists at TD Securities.
At midday, Canada's S&P/TSX Composite Index was 0.95% higher at 20819.49 and the blue-chip S&P/TSX 60 rose by 0.93% to 1256.43.
G2 Goldfields shares were 15% higher at 77 Canadian cents (57 cents) after the company said AngloGold Ashanti intends to make a C$22.1 million investment in the company.
Other market movers:
HIVE Digital Technologies shares were 8.7% higher at C$5.60 after the company said that it plans to raise $25 million on a bought-deal basis private placement. Shares are up 8.5% in Toronto at C$5.59.
Shares in Global Atomic were 6.1% lower at C$2.63 after it said that it expects to raise C$15 million by way of a strategic investment, in part from privately owned Bermuda-based Regent Mercantile Holdings and certain related companies.
Write to Adriano Marchese at adriano.marchese@wsj.com
(END) Dow Jones Newswires
December 19, 2023 12:39 ET (17:39 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.-
What’s the Difference Between the CPI and PCE Indexes?
-
Micron Earnings: Great Guidance but Stock Now Looks Fairly Valued
-
August PCE Report Forecasts Show More Good News on Inflation
-
AI Stocks May Be Down, but Don’t Count Them Out
-
4 Stocks to Buy as the Fed Cuts Interest Rates
-
Markets Brief: The Uncertain Path to Neutral Interest Rates
-
What’s Happening in the Markets This Week
-
Where Top Stock Fund Managers Are Looking Next After the Fed Rate Cut
-
Our Top Pick for Investing in US Renewable Energy
-
How to Measure a Stock’s Uncertainty
-
How to Determine Whether a Stock Is Cheap, Expensive, or Fairly Valued
-
Why a Company’s Management and Capital Allocation Matter
-
How to Determine What a Stock Is Worth
-
How to Measure a Company’s Competitive Advantage
-
How to Think Like a Stock Analyst
-
How GLP-1 Drugs Like Ozempic Are Boosting Biopharma Stocks